Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cell lymphoma: results of a multicenter phase 2 tria
the editor: Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse...
Purpose: High-grade mucoso-associated lymphoid tissue (MALT) lymphomas of the stomach are generally ...
[[abstract]]Background. Several independent clinical studies have reported that Helicobacter pylori ...
Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cel...
An explorative study evaluates the efficacy of Helicobacter pylori (HP) eradication (HPE) therapy on...
PubMedID: 25852262Diffuse large B cell lymphoma (DLBCL) of the stomach is a heterogenous disease. Th...
• Objective: To determine the effect of eradicating Helicobacter pylori infection on the course of l...
Helicobacter pylori eradication is recognized as the initial therapy for gastric low-grade, B-cell, ...
Aim: To assess the remission rate of gastric low-grade B-cell mucosa\u2013associated lymphoid tissue...
A series of studies has shown that Helicobacter pylori eradication induces remission in most patient...
[[abstract]]Background: We have recently demonstrated that early-stage gastric diffuse large B-cell ...
BACKGROUND: Treatment aimed at eradicating Helicobacter pylori infection results in lymphoma remissi...
Background/Aims: Helicobacter pylori eradication therapy has been used as a first-line treatment for...
Background. To evaluate the long-term outcome of H. pylori eradication therapy for gastric MALT lymp...
Abstract Background Treatment of primary gastric diffuse large B-cell lymphoma is still controversia...
the editor: Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse...
Purpose: High-grade mucoso-associated lymphoid tissue (MALT) lymphomas of the stomach are generally ...
[[abstract]]Background. Several independent clinical studies have reported that Helicobacter pylori ...
Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cel...
An explorative study evaluates the efficacy of Helicobacter pylori (HP) eradication (HPE) therapy on...
PubMedID: 25852262Diffuse large B cell lymphoma (DLBCL) of the stomach is a heterogenous disease. Th...
• Objective: To determine the effect of eradicating Helicobacter pylori infection on the course of l...
Helicobacter pylori eradication is recognized as the initial therapy for gastric low-grade, B-cell, ...
Aim: To assess the remission rate of gastric low-grade B-cell mucosa\u2013associated lymphoid tissue...
A series of studies has shown that Helicobacter pylori eradication induces remission in most patient...
[[abstract]]Background: We have recently demonstrated that early-stage gastric diffuse large B-cell ...
BACKGROUND: Treatment aimed at eradicating Helicobacter pylori infection results in lymphoma remissi...
Background/Aims: Helicobacter pylori eradication therapy has been used as a first-line treatment for...
Background. To evaluate the long-term outcome of H. pylori eradication therapy for gastric MALT lymp...
Abstract Background Treatment of primary gastric diffuse large B-cell lymphoma is still controversia...
the editor: Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse...
Purpose: High-grade mucoso-associated lymphoid tissue (MALT) lymphomas of the stomach are generally ...
[[abstract]]Background. Several independent clinical studies have reported that Helicobacter pylori ...